129 related articles for article (PubMed ID: 15650407)
1. Levuglandins and isolevuglandins: stealthy toxins of oxidative injury.
Salomon RG
Antioxid Redox Signal; 2005; 7(1-2):185-201. PubMed ID: 15650407
[TBL] [Abstract][Full Text] [Related]
2. Iso[7]LGD2-protein adducts are abundant in vivo and free radical-induced oxidation of an arachidonyl phospholipid generates this D series isolevuglandin in vitro.
Poliakov E; Meer SG; Roy SC; Mesaros C; Salomon RG
Chem Res Toxicol; 2004 May; 17(5):613-22. PubMed ID: 15144218
[TBL] [Abstract][Full Text] [Related]
3. Generation and detection of levuglandins and isolevuglandins in vitro and in vivo.
Zhang M; Li W; Li T
Molecules; 2011 Jun; 16(7):5333-48. PubMed ID: 21705973
[TBL] [Abstract][Full Text] [Related]
4. New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts.
Roberts LJ; Salomon RG; Morrow JD; Brame CJ
FASEB J; 1999 Jul; 13(10):1157-68. PubMed ID: 10385607
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing levuglandins produced through the cyclooxygenase and isoprostane pathways.
Salomon RG
Chem Phys Lipids; 2005 Mar; 134(1):1-20. PubMed ID: 15752459
[TBL] [Abstract][Full Text] [Related]
6. Isolevuglandin adducts in disease.
Salomon RG; Bi W
Antioxid Redox Signal; 2015 Jun; 22(18):1703-18. PubMed ID: 25557218
[TBL] [Abstract][Full Text] [Related]
7. Oxidized phospholipids, isolevuglandins, and atherosclerosis.
Zhang W; Salomon RG
Mol Nutr Food Res; 2005 Nov; 49(11):1050-62. PubMed ID: 16270278
[TBL] [Abstract][Full Text] [Related]
8. Isolevuglandins covalently modify phosphatidylethanolamines in vivo: detection and quantitative analysis of hydroxylactam adducts.
Li W; Laird JM; Lu L; Roychowdhury S; Nagy LE; Zhou R; Crabb JW; Salomon RG
Free Radic Biol Med; 2009 Dec; 47(11):1539-52. PubMed ID: 19751823
[TBL] [Abstract][Full Text] [Related]
9. The Adductomics of Isolevuglandins: Oxidation of IsoLG Pyrrole Intermediates Generates Pyrrole⁻Pyrrole Crosslinks and Lactams.
Bi W; Jang GF; Zhang L; Crabb JW; Laird J; Linetsky M; Salomon RG
High Throughput; 2019 May; 8(2):. PubMed ID: 31083423
[TBL] [Abstract][Full Text] [Related]
10. Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo.
Poliakov E; Brennan ML; Macpherson J; Zhang R; Sha W; Narine L; Salomon RG; Hazen SL
FASEB J; 2003 Dec; 17(15):2209-20. PubMed ID: 14656983
[TBL] [Abstract][Full Text] [Related]
11. Isolevuglandins (isoLGs) as toxic lipid peroxidation byproducts and their pathogenetic role in human diseases.
Aschner M; Nguyen TT; Sinitskii AI; Santamaría A; Bornhorst J; Ajsuvakova OP; da Rocha JBT; Skalny AV; Tinkov AA
Free Radic Biol Med; 2021 Jan; 162():266-273. PubMed ID: 33099003
[TBL] [Abstract][Full Text] [Related]
12. Protein adducts of iso[4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoprotein.
Salomon RG; Sha W; Brame C; Kaur K; Subbanagounder G; O'Neil J; Hoff HF; Roberts LJ
J Biol Chem; 1999 Jul; 274(29):20271-80. PubMed ID: 10400646
[TBL] [Abstract][Full Text] [Related]
13. Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis.
Salomon RG
Ann N Y Acad Sci; 2005 Jun; 1043():327-42. PubMed ID: 16037255
[TBL] [Abstract][Full Text] [Related]
14. Effects of reactive gamma-ketoaldehydes formed by the isoprostane pathway (isoketals) and cyclooxygenase pathway (levuglandins) on proteasome function.
Davies SS; Amarnath V; Montine KS; Bernoud-Hubac N; Boutaud O; Montine TJ; Roberts LJ
FASEB J; 2002 May; 16(7):715-7. PubMed ID: 11978738
[TBL] [Abstract][Full Text] [Related]
15. Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway.
Salomon RG; Batyreva E; Kaur K; Sprecher DL; Schreiber MJ; Crabb JW; Penn MS; DiCorletoe AM; Hazen SL; Podrez EA
Biochim Biophys Acta; 2000 May; 1485(2-3):225-35. PubMed ID: 10832102
[TBL] [Abstract][Full Text] [Related]
16. Isolevuglandins as a gauge of lipid peroxidation in human tumors.
Yan HP; Roberts LJ; Davies SS; Pohlmann P; Parl FF; Estes S; Maeng J; Parker B; Mernaugh R
Free Radic Biol Med; 2017 May; 106():62-68. PubMed ID: 28189846
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-dependent lipid-modification of brain proteins.
Boutaud O; Andreasson KI; Zagol-Ikapitte I; Oates JA
Brain Pathol; 2005 Apr; 15(2):139-42. PubMed ID: 15912886
[TBL] [Abstract][Full Text] [Related]
18. Levuglandin E2-protein adducts in human plasma and vasculature.
Salomon RG; Subbanagounder G; O'Neil J; Kaur K; Smith MA; Hoff HF; Perry G; Monnier VM
Chem Res Toxicol; 1997 May; 10(5):536-45. PubMed ID: 9168251
[TBL] [Abstract][Full Text] [Related]
19. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation.
Roberts LJ; Fessel JP
Chem Phys Lipids; 2004 Mar; 128(1-2):173-86. PubMed ID: 15037162
[TBL] [Abstract][Full Text] [Related]
20. Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation.
Roberts LJ; Morrow JD
Cell Mol Life Sci; 2002 May; 59(5):808-20. PubMed ID: 12088281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
